RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $115

Benzinga · 3d ago
RBC Capital analyst Kendall Au maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $110 to $115.